Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP (Q66392955)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP |
clinical trial |
Statements
Long-Term Tolerability and Safety of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) (English)
0 references
12 December 2016
0 references
30 September 2024
0 references
149
0 references
18 year
0 references